In acute myeloid leukaemia, Axl activation is involved in immune evasion via the upregulation of BCL-2 and Twist, the suppression of TLR inflammatory signalling and the limited expression of pro-inflammatory cytokines [53,54]. Here, AXL is linked to acute myeloid leukemia.